If FDA ask for another longer trial, ADMD will need to sell the additional 1.5 Billions shares that they are asking for, plus a R/S to solvent this trial, but if the product got approved, shares will be higher and ADMD will need to sell a few millions shares only to start production.
Market Data 
Markets 
AI
